Applied Health Economics And Health Policy
Points Position
CEF.UP+NIPE (average of all rankings) (2012) 5.63 465/501
Australian RC (2010) 25.0 464/479
CNRS (2008) 20.0 311/336
Ideas discounted recursive impact factor (2012) 0.2 342/396
Source Normalized Impact per Paper (SNIP) (2011) 5.69 375/476
Count 1.0 471/632
SJR (2016) 0.81 214/470
Articles 3:

Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy
Ana Teresa Paquete, Luis Silva Miguel, Ursula Becker, Catarina Pereira, Carlos Gouveia Pinto
vol. 15, 2017, p. 501-512.

Cost-Effectiveness Analysis of 3-D Computerized Tomography Colonography versus Optical Colonoscopy for Imaging Symptomatic Gastroenterology Patients
Manuel Gomes, Robert W. Aldridge, Peter Wylie, James Bell, Owen Epstein
vol. 11, 2013, p. 107-117.

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha, Jagpreet Chhatwal, Shannon A. Ferrante, Antoine C. El Khoury, Pedro A. Laires
vol. 11, 2013, p. 65-78.